In ₹ Crore except Per Share Latest Annual | SARVESHWAR FY26 | SUKHJITS FY26 | NATHBIOGEN FY26 | INDOUS FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 13.76× | 28.32× | ◆ 7.27× | 12.28× | 12.28× +12% | |
| P/B | 1.03× | 0.88× | ◆ 0.43× | 1.74× | 0.88× +17% | |
| EV/EBITDA | 11.15× | 9.14× | ◆ 6.72× | 11.29× | 9.14× +22% | |
| Market Cap | ₹491 Cr | ₹500 Cr | ₹290 Cr | ₹161 Cr | ₹290 Cr +70% | |
| Growth | ||||||
| Revenue CAGR 3Y | ◆ 24.98% | -0.33% | 13.88% | — | 6.78% +269% | |
| Net Income CAGR 3Y | ◆ 59.78% | -24.72% | 5.93% | — | -9.39% +736% | |
| Revenue YoY (latest Q) | ◆ 18.81% | 7.18% | 15.76% | 7.21% | 7.21% +161% | |
| Net Income YoY (latest Q) | 17.04% | ◆ 142.51% | -13.46% | -35.41% | -13.46% +227% | |
| Profitability | ||||||
| EBITDA Margin | 4.91% | 5.77% | 11.78% | ◆ 15.40% | 11.78% -58% | |
| Net Income Margin | 2.36% | 1.89% | 9.35% | ◆ 11.88% | 9.35% -75% | |
| Return on Common Equity | 6.66% | 4.76% | 6.12% | ◆ 14.18% | 6.12% +9% | |
| Return on Capital Employed | 13.34% | 6.37% | 6.90% | ◆ 17.22% | 6.90% +93% | |
| Return on Assets | 2.92% | 2.48% | 3.79% | ◆ 9.86% | 3.79% -23% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.52× | 0.58× | ◆ 0.20× | 0.40× | 0.40× +30% | |
| Interest Coverage | 2.44× | 1.54× | 3.03× | ◆ 7.18× | 3.03× -19% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹1,346 Cr | ₹1,432 Cr | ₹445 Cr | ₹110 Cr | ₹445 Cr +202% | |
| Net Income | ₹31.8 Cr | ₹27 Cr | ₹41.6 Cr | ₹13.1 Cr | ₹27 Cr +18% | |
| Total Assets | ₹1,089 Cr | ₹1,089 Cr | ₹1,097 Cr | ₹133 Cr | ₹1,089 Cr -0% | |
| EPS | ₹0.29 | ₹5.65 | ₹20.98 | ₹6.54 | ₹6.54 -96% | |
| Book Value per Share | ₹3.88 | ₹181.62 | ₹358.06 | ₹46.15 | ₹181.62 -98% | |